All stories
Market Pulse

Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company

Kenvue shares stopped trading on Nov 2, 2026. Each one became $3.50 in cash plus 0.14625 Kimberly-Clark shares, and most of the promised $2.1 billion in savings comes from cutting costs.

Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company — slide 1 of 6Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company — slide 2 of 6Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company — slide 3 of 6Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company — slide 4 of 6Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company — slide 5 of 6Kimberly-Clark closes Kenvue deal: Huggies and Tylenol now share one company — slide 6 of 6
Swipe through 6 slides →

On Nov 2, 2026, Kimberly-Clark said it had completed its acquisition of Kenvue. The company that makes Huggies diapers and Kleenex tissues now also owns the company behind Tylenol, Listerine and Neutrogena. Kenvue's stock, which traded under the ticker KVUE, stopped trading on the New York Stock Exchange at the open that day.

Free · No card, no paywall

Keep reading for free.

You’ve read about 14% of this story. Join The Finvestex Brief — free — to unlock every story and archive edition in full, and get the next Brief at 8:45 a.m. ET.

Every trading day · Free · Unsubscribe anytime. By subscribing you agree to our Privacy Policy.

Already subscribed? Enter your email above to unlock this browser.

General market information for educational purposes — not investment advice. Figures come from the linked sources.